Could Medical Facilities Corp Recover After Today’s Huge Decline?

 Could Medical Facilities Corp Recover After Today's Huge Decline?

The stock of Medical Facilities Corp (TSE:DR) is a huge mover today! About 35,143 shares traded hands. Medical Facilities Corp (TSE:DR) has risen 3.05% since April 22, 2016 and is uptrending. It has underperformed by 2.97% the S&P500.
The move comes after 7 months negative chart setup for the $546.45 million company. It was reported on Nov, 28 by We have $16.96 PT which if reached, will make TSE:DR worth $21.86 million less.

Medical Facilities Corp (TSE:DR) Ratings Coverage

Out of 3 analysts covering Medical Facilities Corp (TSE:DR), 3 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. $25 is the highest target while $17.50 is the lowest. The $19.88 average target is 12.51% above today’s ($17.67) stock price. Medical Facilities Corp has been the topic of 6 analyst reports since August 14, 2015 according to StockzIntelligence Inc. The firm earned “Outperform” rating on Tuesday, November 22 by RBC Capital Markets. The stock has “Sector Perform” rating given by National Bank Canada on Monday, August 17. The stock of Medical Facilities Corp (TSE:DR) has “Buy” rating given on Friday, November 11 by TD Securities. TD Securities maintained the shares of DR in a report on Friday, October 7 with “Buy” rating.

Medical Facilities Corporation is a Canada company, which owns interests in over six entities , approximately five of which either own a specialty surgical hospital (SSH) or an ambulatory surgery center (ASC). The company has a market cap of $546.45 million. The Company’s Centers offer facilities, such as staff, surgical materials and supplies, and other support necessary for scheduled surgical, pain management, imaging and diagnostic procedures. It currently has negative earnings. The Centers focus on clinical specialties, such as orthopedic, neurosurgery, pain management and other non-emergency elective procedures.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment